I presented my Buy thesis on Stryker Corporation (NYSE: SYK ) in December 2023, pointing out the potential launch of Mako shoulder and spine applications. Since then, the stock price has increased by more than 28%, outperforming the S&P 500 index (Analyst’s Disclosure: I/we have a beneficial long position in the shares of SYK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Se ...